Delamanid in the treatment of multidrug-resistant tuberculosis
R Gupta, CD Wells, N Hittel, J Hafkin… - … International Journal of …, 2016 - ingentaconnect.com
Otsuka has been engaged in anti-tuberculosis drug development efforts for over 30 years,
and is the leading private sector funder of tuberculosis (TB) research and development …
and is the leading private sector funder of tuberculosis (TB) research and development …
WHO recommendations on shorter treatment of multidrug-resistant tuberculosis
Comment www. thelancet. com Vol 387 June 18, 2016 2487 and meropenem-sparing and
imipenem-sparing, regimens. The majority of the M tuberculosis strains that were isolated …
imipenem-sparing, regimens. The majority of the M tuberculosis strains that were isolated …
Standards for clinical trials for treating TB
BACKGROUND: The value, speed of completion and robustness of the evidence generated
by TB treatment trials could be improved by implementing standards for best practice …
by TB treatment trials could be improved by implementing standards for best practice …
Good collaborative practice: reforming capacity building governance of international health research partnerships
In line with the policy objectives of the United Nations Sustainable Development Goals, this
commentary seeks to examine the extent to which provisions of international health research …
commentary seeks to examine the extent to which provisions of international health research …
[HTML][HTML] COVID-19 site readiness initiative: building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemic
SAC Clemens, AK Sekine, F Tovar-Moll, R Clemens - Vaccine: X, 2022 - Elsevier
Abstract According to the World Health Organization, the American region has the highest
coronavirus disease-2019 (COVID-19) cases and deaths since the start of the pandemic …
coronavirus disease-2019 (COVID-19) cases and deaths since the start of the pandemic …
Implementation challenges and lessons learned from the STREAM clinical trial—a survey of trial sites
LN Patel, M Gurumurthy, G Bronson, K Sanders… - Trials, 2023 - Springer
Background Design and implementation of multi-country clinical trials for multidrug-resistant
tuberculosis (MDR-TB) are complex for several reasons, including trial duration, varying …
tuberculosis (MDR-TB) are complex for several reasons, including trial duration, varying …
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic
E Ariza-Vioque, F Ello, H Andriamamonjisoa… - Infectious Diseases and …, 2022 - Springer
Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB),
with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co …
with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co …
Clinical research in neglected tropical diseases: the challenge of implementing good clinical (laboratory) practices
R Ravinetto, E Alirol, Y Mahendradhata… - PLoS neglected …, 2016 - journals.plos.org
Pharmaceutical research and development (R&D) historically neglected the infectious
diseases that mainly or exclusively affect poor communities in low-and middle-income …
diseases that mainly or exclusively affect poor communities in low-and middle-income …
[PDF][PDF] Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials
A Zumla, I Abubakar - The Lancet Respiratory Medicine, 2017 - discovery.ucl.ac.uk
1 Comment for Lancet Respiratory Medicine - Clinical trial research in focus: Title: Multi-drug
resistant Tuberculosis – ov Page 1 1 Comment for Lancet Respiratory Medicine - Clinical trial …
resistant Tuberculosis – ov Page 1 1 Comment for Lancet Respiratory Medicine - Clinical trial …
Capacity building in Sub-Saharan Africa as part of the INTENSE-TBM project during the COVID-19 pandemic [Commentaire]
E Ariza-Vioque, F Ello, H Andriamamonjisoa… - 2022 - documentation.ird.fr
Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB),
with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co …
with at least 100,000 cases per year and a mortality rate of up to 50% in individuals co …